onkuretherapeutics.com - OKUR Operating profit EBITDA

Graphic logo of OnKure Therapeutics (OKUR)

The current EBITDA_Co dynamics highlight the binary risks of a narrow-focus, early-stage venture biotech. OnKure Therapeutics Inc (OKUR) is developing targeted HDAC inhibitors to combat resistant tumors amidst intense scientific competition. A precision approach to mutations establishes the foundation for a future patent monopoly and significant pricing power. The value of 0.00 captures the operating profit metric level.

OKUR - OnKure Therapeutics Operating profit EBITDA over the range 11/23/2025 - 11/17/2026

Summary analytical data breakdowns for onkuretherapeutics.com (OKUR)

- current quotes and average value forecast:
Analysis of all company metrics:OKUR (OnKure Therapeutics, Inc.)
Manufactured product of OnKure Therapeutics Inc

This indicator reflects the total cash flow generated by core commercial activities minus depreciation, demonstrating the business's actual ability to extract profit from operational processes. By analyzing the trend of operating profit before interest and taxes, an investor can assess the monetization efficiency of the OnKure Therapeutics patent portfolio in the development of high-cost precision oncology drugs.

Competitor analysis for OnKure Therapeutics Inc

Operating profit EBITDA beigene.com ONC|HALO: Operating profit before deduction of amortization|RVMD - Operating profit EBITDA|Ascentage (AAPG) - Profit before payment of interest, taxes and amortization|CG Oncology Corp - Income before deduction of interest, taxes and amortization|URGN (UroGen Pharma Ltd) - Operating profit EBITDA|Profit before interest, taxes and amortization Bicara Therapeutics Inc. BCAX|Profit before payment of interest, taxes and amortization Personalis, Inc. (PSNL)|ERAS - Profit before interest, taxes and amortization|Operating profit EBITDA DCTH (delcath.com)|Operating profit before depreciation charges Y-mAbs Corp|AURA - Profit before payment of interest, taxes and amortization|CADL (candeltx.com) - Operating profit before amortization|ARAY (accuray.com) - Operating profit before deduction of amortization|SELLAS Life Sciences Group Inc. (SLS) - Operating profit EBITDA|ACTU (Actuate Therapeutics Inc.) - Operating profit EBITDA|Operating profit EBITDA Citius Oncology Inc|Operating profit EBITDA HURA|TARA (Protara Therapeutics) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA FATE (Fate Therapeutics)|Operating income before deduction of amortization Aadi Bioscience Inc (WHWK)|TScan Therapeutics, Inc. - Operating profit EBITDA|CSBR (Champions Oncology, Inc.) - Operating profit before amortization|XBIT (XBiotech USA) - Operating profit before deduction of amortization|Profit before interest, taxes and amortization CEL-SCI Corp (CVM)|OSTX (OS Therapies Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization Radiopharm Theranostics (RADX)|Operating profit before deduction of amortization ARTV (Artiva Biotherapeutics, Inc.)|ANL - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Veru Inc. VERU|Income before deduction of interest, taxes and amortization TPST|XLO: Operating profit before deduction of amortization|Operating income before deduction of amortization Renovaro RENB|MURA (muraloncology.com) - Operating profit before deduction of amortization|Kairos Pharma Inc - Income before deduction of interest, taxes and amortization|GDTC (CytoMed Therapeutics Ltd) - Operating profit EBITDA|Operating profit before deduction of amortization Curis, Inc. (CRIS)|Operating profit EBITDA APLM|Company profit before taxes, interest and amortization THAR|Operating profit EBITDA ADVB (advanbiomed.com)|GNPX - Operating profit before deduction of amortization|CLDI: Operating profit before deduction of amortization|SBFM - Operating profit EBITDA|Xenetic Biosciences (XBIO) - Profit before payment of interest, taxes and amortization|SLRX: Company profit before taxes, interest and amortization|PPBT (Purple Biotech Ltd) - Operating profit EBITDA|Profit before interest, taxes and amortization American Oncology Network, Inc. AONC|Operating profit EBITDA BGNE|Operating income before deduction of amortization Checkpoint Therapeutics|Elevation Oncology, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA iCAD, Inc. ICAD|Ikena Oncology, Inc. - Operating profit EBITDA|NTBL - Operating profit EBITDA|VIRX (Viracta Therapeutics) - Operating profit before deduction of amortization|MorphoSys AG - Income before deduction of interest, taxes and amortization|NAYA (NAYA Biosciences Corp) - Operating profit EBITDA|Operating profit EBITDA Ascentage Pharma Group International